Evaluations & learnings

Evaluations provide independent assessments of our work, help us make adjustments and plan for the future.

Our evaluation framework is based on the internationally accepted evaluation framework of the Organization for Economic Co-operation and Development’s Development Assistance Committee, including its principles and criteria for grant evaluations. The framework was updated in 2022 to align with our 2023-2027 Strategy.

We require at least one evaluation for each investment or portfolio of investments, typically conducted within 12 months of closure. We also conduct prospective evaluations to facilitate real-time learning and thematic evaluations to review performance and capture learning within cross-cutting areas of our strategic framework.

Upcoming evaluations

There are no current evaluations planned. Check back regularly for updates.

August 2016

End-of-project evaluation: Creating a private sector market for quality-assured malaria RDTs

Evaluation report

July 2016

End-of-project evaluation: ESTHERAID

Evaluation report

January 2016

Mid-term evaluation: Market-entry of fixed-dose combinations for children with HIV/AIDS

Evaluation report

November 2015

Mid-term evaluation: Improving severe malaria outcomes (ISMO) project

Evaluation report

May 2015

Mid-term evaluation: TBXpert – Innovative diagnostics for multi-drug resistant tuberculosis (MDR-TB)

Evaluation report

March 2015

Mid-term evaluation: Addressing neglected childhood tuberculosis (STEP-TB)

Evaluation report

March 2015

End-of-project evaluation: Support for MDR-TB scale-up initiative

Evaluation report

January 2015

Evaluation of OPP-ERA project (phase 2)

Evaluation report
1 3 4 5 6 7 8